MedTrace Logo

An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Healthy Male Participants

NCT03739788 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2021-02-26

No results posted yet for this study

Summary

The purpose of this study is to investigate BMS-986165 given as a tablet in healthy male participants.

Conditions

  • Healthy Participants

Interventions

DRUG

BMS-986165

Oral administration of tablet and 15-minute intravenous BMS-986165 solution for infusion

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-05
Primary Completion
2019-02-11
Completion
2019-02-11
FDA Drug
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03739788 on ClinicalTrials.gov